NasdaqHealth CarePharmaceutical PreparationsCAMBRIDGE, MA

Wave Life Sciences, Inc. WVE

Ask your AI

Estimated market cap $617.33M197.23M shares, shares as of Oct 21, 2026CIK 1631574

Insider trades, 12 mo

5 buys · 46 sells

$16.07M sold, open market

Congress trades, 24 mo

—

No disclosed trades

13F holders, Q3 2026

141

52.4% of shares · 1 added

13F holders

…

Lobbying, 12 mo

—

No lobbying filings

Federal contracts, 12 mo

—

None matched

Ask your AI:

Latest 10-Q

Q3 2026

What changed in Wave Life Sciences, Inc.'s latest quarterly report, compared with the one before.

Filed Oct 27, 2026 · Quarter ended Sep 30, 2026

Compared with the 10-Q for the quarter ended Jun 30, 2026. Sections compared: management's discussion, risk factors, legal proceedings and controls and procedures.

Read the 10-Q on sec.gov ↗Filing index ↗

Latest 10-Q

What changed in Wave Life Sciences, Inc.'s latest quarterly report, compared with the one before.

Loading…

Insider trades

51 in 12 mo

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

No open-market insider trades reported since Aug 12, 2026. Insiders have two business days to file.

Recent insider trades

Adrian Rawcliffe Director	Aug 12 Form 4 ↗	Sale 10b5-1 plan	−$67.2K 12,700 sh @ $5.29	-37.9%
Ken Takanashi Director	Aug 11 Form 4 ↗	Sale 10b5-1 plan	−$23.2K 3,864 sh @ $6.01	-35.9%
Tan Aik Na Director	Aug 11 Form 4 ↗	Sale 10b5-1 plan	−$2,596 432 sh @ $6.01	-35.9%
Heidi L. Wagner Director	Aug 11 Form 4 ↗	Sale 10b5-1 plan	−$42.1K 7,000 sh @ $6.01	-35.9%
Ra Capital Management, L.P. Director, 10% owner	Mar 30 Form 4 ↗	Buy	+$6.3M 971,091 sh @ $6.50	-72.1%

All WVE insider trades →Planned sales (Form 144): see notices

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

Loading…

13F holders

103.27M shares

141 funds report WVE. Values checked against market prices.

Funds own 0.2% of shares (Q2 2026)

1 fund holds the stock.

Q3 2026: 52% · 5,560 of ~8,900 funds reported so far

Q2 20260.2%
Q3 2026 (so far)52%

Q3 2026. 139 new, 1 added to, 0 trimmed, 0 exited since Q2 2026.

Top 13F holders
#
1	BlackRock, Inc. 13F ↗	21.09M	$78.0M	New
2	GSK plc 13F ↗	18.25M	$67.5M	New
3	State Street Corp 13F ↗	5.66M	$20.9M	New
4	Primecap Management Co 13F ↗	5.13M	$19.0M	New
5	M28 Capital Management LP 13F ↗	4.59M	$17.0M	New
6	FMR LLC 13F ↗	3.84M	$14.2M	New
7	Qube Research & Technologies Ltd 13F ↗	3.68M	$13.6M	New
8	Marshall Wace, LLP 13F ↗	3.66M	$13.6M	New
9	Geode Capital Management, LLC 13F ↗	3.52M	$13.0M	New
10	UBS Group AG 13F ↗	2.90M	$10.7M	New

Download CSV Every fund that holds WVE, not only these ten. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

13F holders

Funds that report this stock, checked against market prices.

Loading…

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

No recent congressional trades for this company.

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

Loading…

Lobbying

What Wave Life Sciences, Inc. and its lobbying firms report each quarter.

No recent lobbying filings for this company.

Lobbying

What Wave Life Sciences, Inc. and its lobbying firms report each quarter.

Loading…

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Funds holding the stock

Shares they report

Funds holding the stock by quarter

Q2 2026	1	—	429,121	$2.5M
Q3 2026	141	+140	103.27M	$382.2M

Each point is a quarter-end, from Q2 2026 to Q3 2026. A fund's 13F lists its long positions in US-listed securities as of the last day of the quarter and arrives up to 45 days later, so each point shows holdings at quarter-end, not on the day they were reported.

Common shares only; options and bonds are left out. When a fund amends a report, the amended version is the one counted.

The history follows the company's current CUSIP number (94352A104). If the company's shares were ever re-issued under a different CUSIP, the quarters before the change are not part of this series, so the first point (Q2 2026) can be later than the stock's first appearance in 13F reports.

Share counts are adjusted for stock splits; none took place between these quarters. Values are in dollars as reported at the time and are not adjusted.

A quarter appears once our daily update has built its summary. If a summary cannot be built, older reports are kept and the chart shows the quarters it has until the next update repairs it.

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Loading…

More filings and data

Each opens the table.

Ownership stakes10 in 12 mo 8-K events1 in 90 days Patents14 patents granted Short interestFINRA · updated Oct 15 Planned insider salesForm 144 · 14 in 12 mo Executive pay5 fiscal years Wikipedia attentionNone on record SEC enforcementNone on record IPO history1 registration Ownership stakes…8-K events…Patents…Short interest…Planned insider sales…Executive pay…Wikipedia attention…SEC enforcement…

About the company

The basics from the company’s SEC registration.

Legal name: Wave Life Sciences, Inc.
Address: 733 CONCORD AVENUE, CAMBRIDGE, MA 02138
Phone: 617-949-2900
Fiscal year ends: Dec 31
Filer category: Large accelerated filer
Incorporated in: DE
Listed as: WVE (Nasdaq)
Former names: Wave Life Sciences Ltd. (until 2026); Wave Life Sciences LTD. (until 2026); WAVE Life Sciences Ltd. (until 2026); Wave Life Sciences Pte Ltd (until 2015)
SEC filings: All filings on SEC EDGAR ↗

About the company

The basics from the company’s SEC registration.

Loading…

$3.13−$0.02 (−0.79%) Nov 13 close

1M3M1Y

Oct 13, 2026Low $3.09 · High $3.64Nov 13, 2026

Aug 13, 2026Low $3.09 · High $5.42Nov 13, 2026

Nov 13, 2025Low $3.09 · High $21.31Nov 13, 2026

Congress purchase Congress sale Insider sale over $1M

Adjusted for stock splits; not for dividends. Where prices come from.

Live chart

Intraday and historical prices from TradingView. Quotes may be delayed.

Loading chart…

Information, not investment advice. Company matching is automatic; check the source before relying on one row.